NEWS

BIOSORTIA – AT SCALE MINING OF NATURE’S METABOLITE BOUNTY

Nature- biopharmadealmakers (November 30, 2020)

Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approaches. Biosortia is seeking partners interested in accessing compounds and chemistries to develop biologically relevant small molecule leads.

Continue Reading >>

CYANOBUFALINS: CARDIOACTIVE TOXINS FROM CYANOBACTERIAL BLOOMS
Columbus, OH (October 28, 2018) – Journal of Natural Products
Biosortia Demonstrated Products
  1. Aquatic microbiomes contain novel chemistry
  2. Novel chemistry previously undetectable & inaccessible
  3. Biosortia has proven capability of accessing previously undetectable and inaccessible chemistry in volumes sufficient for drug discovery

Continue Reading >>

NEW TECHNOLOGY ACCESSES SMALL BUT MIGHTY MICROORGANISMS
NewsUSA (October 9, 2019) – 11|KTVA
More medicines may be developed faster in the near future, thanks to new technology that harnesses the tiny particles that make drug development possible. Microorganisms grown in laboratories have been the starting point for many medicines we have today. However, many more microorganisms exist in nature that can’t be grown in a lab because they are too small, too fragile, or evolve too rapidly.

Continue Reading >>

Pin It on Pinterest